New hope for rare brain disease: platform trial targets PSP
Disease control
Recruiting now
This study tests several experimental treatments for progressive supranuclear palsy (PSP), a rare brain disease that affects movement and thinking. About 440 people with early-stage PSP will receive one of the treatments or a placebo. The goal is to see if any of the treatments c…
Phase: PHASE2 • Sponsor: Adam Boxer • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC